Aktive Positionen von Yves Gonnissen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SEPS Pharma NV
 SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | Direktor/Vorstandsmitglied | 20.05.2011 | - |
| Vorstandsvorsitzender | 19.10.2007 | - | |
| Gründer | 19.10.2007 | - | |
Amatsigroup SAS
 Amatsigroup SAS BiotechnologyHealth Technology Amatsigroup SASU provides human and veterinary drug development services. It offers bio services, pharmaceutical analysis solutions, formulation development, and manufacturing and clinical trial supply packaging and logistics. The company was founded on October 12, 2010 and is headquartered in Fontenilles, France. | Vorsitzender | 29.06.2018 | - |
Eurofins Amatsigroup NV
 Eurofins Amatsigroup NV BiotechnologyHealth Technology Part of Eurofins Scientific SE, Eurofins Amatsigroup NV engages in the development of biological drugs. The company is based in Ghent, Belgium. The Belgian company was founded in 2007. The CEO is Yves Gonnissen. | Direktor/Vorstandsmitglied | 15.01.2015 | - |
| Vorstandsvorsitzender | 30.06.2017 | - |
Karriereverlauf von Yves Gonnissen
Ehemalige bekannte Positionen von Yves Gonnissen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Ausbildung von Yves Gonnissen
| Ghent University | Doctorate Degree |
| Université Catholique de Louvain | Graduate Degree |
Statistik
International
| Belgien | 5 |
| Vereinigte Staaten | 3 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 4 |
|---|---|
SEPS Pharma NV
SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Amatsigroup SAS
Amatsigroup SAS BiotechnologyHealth Technology Amatsigroup SASU provides human and veterinary drug development services. It offers bio services, pharmaceutical analysis solutions, formulation development, and manufacturing and clinical trial supply packaging and logistics. The company was founded on October 12, 2010 and is headquartered in Fontenilles, France. | Health Technology |
Eurofins Amatsigroup NV
Eurofins Amatsigroup NV BiotechnologyHealth Technology Part of Eurofins Scientific SE, Eurofins Amatsigroup NV engages in the development of biological drugs. The company is based in Ghent, Belgium. The Belgian company was founded in 2007. The CEO is Yves Gonnissen. | Health Technology |
- Börse
- Insiders
- Yves Gonnissen
- Erfahrung
